Analgesics - Tunisia

  • Tunisia
  • In Tunisia, the revenue generated in the Analgesics market reaches US$38.49m in 2024.
  • This market is projected to experience an annual growth rate of 6.30% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue, amounting to US$7,243.00m in 2024.
  • Considering the total population, the per person revenue stands at US$3.06 in 2024.
  • Tunisia's analgesics market is experiencing a surge in demand for traditional herbal remedies.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Tunisia has been experiencing significant growth in recent years.

Customer preferences:
Customers in Tunisia have shown a growing preference for analgesic products that provide quick and effective relief from pain. They are increasingly seeking out products that are easy to use and have minimal side effects. Additionally, there is a growing demand for natural and herbal analgesics, as customers are becoming more health-conscious and are seeking alternatives to traditional pharmaceutical products.

Trends in the market:
One of the key trends in the Analgesics market in Tunisia is the increasing availability and popularity of over-the-counter (OTC) analgesics. As the healthcare system in Tunisia continues to improve, more people are gaining access to healthcare services and are therefore able to self-medicate. This has led to a rise in the demand for OTC analgesics, as they are convenient and readily available without a prescription.Another trend in the market is the growing use of online platforms for purchasing analgesic products. With the increasing penetration of internet and smartphones in Tunisia, more customers are turning to online channels to buy their healthcare products. This trend is further fueled by the convenience and competitive pricing offered by online retailers. As a result, traditional brick-and-mortar pharmacies are facing increased competition and are adapting their business models to include online sales.

Local special circumstances:
Tunisia has a relatively young population, with a large proportion of the population falling within the working-age group. This demographic trend has contributed to the growth of the Analgesics market, as younger individuals are more likely to engage in physically demanding activities and are therefore more prone to experiencing pain and injuries. Additionally, the increasing urbanization in Tunisia has led to a more sedentary lifestyle, which has also contributed to the demand for analgesic products.

Underlying macroeconomic factors:
The growing economy in Tunisia has played a significant role in the development of the Analgesics market. As the country continues to experience economic growth, disposable incomes are increasing, allowing more people to afford healthcare products. This has led to a rise in the demand for analgesics, as people are willing to spend more on their health and well-being.Furthermore, the government in Tunisia has been taking steps to improve the healthcare system and increase access to healthcare services. This has resulted in an increase in the number of healthcare facilities and pharmacies, which has further contributed to the growth of the Analgesics market.In conclusion, the Analgesics market in Tunisia is experiencing growth due to changing customer preferences, such as a preference for quick and effective relief from pain and a growing demand for natural and herbal products. The market is also influenced by trends such as the increasing availability of OTC analgesics and the rise of online sales. Local special circumstances, such as a young population and increasing urbanization, have also contributed to the market's development. Finally, underlying macroeconomic factors, such as economic growth and government efforts to improve the healthcare system, have further fueled the growth of the Analgesics market in Tunisia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)